OUE FY2025 adjusted EBIT swings to loss of SGD 15.1 million from profit, revenue SGD 617.0 million down 4.6%

Reuters
02/27
OUE FY2025 adjusted EBIT swings to loss of SGD 15.1 million from profit, revenue SGD 617.0 million down 4.6%

OUE posted FY2025 revenue of SGD 617.0 million (down 4.6%) and a loss attributable to shareholders of SGD 279.1 million (narrowed 2.7%). Adjusted EBIT was a loss of SGD 15.1 million, compared with adjusted EBIT of SGD 63.4 million in FY2024. The group cited mainly non-cash items behind the loss, including share of losses in equity-accounted investees, an impairment loss on an equity-accounted investee and fair value changes on investment properties; it also said it had sufficient liquidity, with net gearing of 53.8% as at 31 December 2025. By segment, FY2025 real estate revenue was SGD 412.4 million (down 7.7%), healthcare revenue was SGD 152.7 million (up 0.3%), and others revenue was SGD 52.0 million (up 9.8%). Share of results of equity-accounted investees was a loss of SGD 230.0 million. OUE declared a final tax-exempt dividend of SGD 0.01 per share for FY2025, taking total FY2025 cash dividend to SGD 0.02 per share including the interim payout. Key updates included breaking ground on the 255-room Hotel Indigo Changi Airport project (completion slated for 2028) and securing a SGD 130.0 million green loan for it; OUE REIT’s refinancing of OUE Bayfront via a SGD 600.0 million green loan and additional facilities, the establishment of a SGD 500.0 million commercial paper programme, and the issuance of SGD 150.0 million 7-year green notes at a 2.75% coupon. OUE REIT also agreed to acquire a 19.9% stake in Salesforce Tower in Sydney at an agreed property value of AUD 357.2 million, with purchase consideration of AUD 195.5 million. In healthcare, OUE increased its stake in OUE Healthcare to 89.68% after acquiring an additional 19.32% in late December 2025, while Healthway Medical Group expanded to over 130 clinics and medical centres and refinanced its acquisition loan with a SGD 60.0 million term loan and a SGD 40.0 million revolving credit facility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OUE Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: A7UBJZG15NVP4JMN) on February 27, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10